Citryll Strengthens Intellectual Property Portfolio With Grant of European Composition of Matter Patent for CIT-013
Expected to provide exclusivity into 2039 Oss, Netherlands – 15 April 2026 – Citryll, a biotech company pioneering a transformative…
